fbpx
Home Tags Pharmaceuticals

Tag: pharmaceuticals

Exclusive: Boehringer Ingelheim USA President/CEO Jean-Michel Boers on firm’s 50th anniversary,...

“The speed at which the industry was able to offer highly efficacious vaccinations is quite extraordinary,” Boers marvels. “It shows how important it is to invest in health care in the U.S.”

MannKind expecting to ‘practically double in size’ with new hires in...

The drugmaker is looking to hire over 100 people in anticipation of FDA approval of Tyvaso DPI, used to treat pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.

Cybercriminals went after companies involved in Covid-19 response, IBM report finds

A computer security study by IBM finds companies and organizations involved in responding to the Covid-19 pandemic were attacked by cybercriminals twice as often...

Jean-Michel Boers succeeding Wolfgang Baiker as head of Boehringer Ingelheim U.S.

Boers joined Boehringer Ingelheim in 1998 in Belgium, and came to the U.S. in 2016 as senior vice president of the Specialty Care Franchise; he has led the U.S. Human Pharma business since January 2017.

IBM: Average data breach costs U.S. companies $8.19M

The report found that on average it took a company 279 days to realize that its data had been hacked or otherwise compromised and take action dealing with the breach.

CT AG Tong leads 44-state coalition in lawsuit against generic drug...

The lawsuit, which New York State is also part of, charges price-fixing and market-rigging for the sale of more than 100 generic drugs.

Great Point Partners sells Clinical Supplies Management to British pharmaceutical firm

The deal involves an initial cash consideration of $150 million on a cash-free and debt-free basis, plus an additional $90 million based on revenue goals.

Boehringer Ingelheim, Vanderbilt U. announce new anticancer collaboration

This is the third collaboration between Ridgefield-based Boehringer Ingelheim and Vanderbilt to develop novel anticancer compounds.

Marcelo Bigal named chief medical officer at Purdue Pharma

Bigal comes to Purdue from Teva Pharmaceuticals, where he most recently served as chief scientific officer for its specialty organization.

Connecticut unveils ‘Change the Script’ campaign against opioid crisis

The new initiative will present educational materials focusing on opioid abuse prevention, treatment, and recovery strategies.

Conn. AG Jepsen says generic drug suit ‘tip of the iceberg’

Referring to the initial lawsuit as "the tip of the iceberg," Jepsen stated that "the prices of many generic drugs have skyrocketed.”

South Carolina AG sues Purdue Pharma over opioid marketing

The lawsuit claims Purdue Pharma exaggerated the benefits of its opioids in comparison to other pain management solutions.

Ridgefield First Selectman Rudy Marconi weighs joining national suit against opioid...

"Connecticut has to get a lot more serious" about approaching the opioid abuse epidemic, Rudy Marconi said.

Boehringer Ingelheim sees worldwide net sales rise by 7 percent

The German company eliminated some 180 positions at its North American headquarters in Ridgefield last year.

Washington city sues Stamford’s Purdue Pharma for ‘enabling’ OxyContin black market

Purdue is accused of being "accountable for knowingly, recklessly, and/or negligently supplying OxyContin to obviously suspicious physicians and pharmacies," among other things.